» Articles » PMID: 3084386

Arthropathic Properties of Gonococcal Peptidoglycan Fragments: Implications for the Pathogenesis of Disseminated Gonococcal Disease

Overview
Journal Infect Immun
Date 1986 May 1
PMID 3084386
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the arthropathic activity of purified peptidoglycan (PG) fragments derived from (i) lysozyme-resistant, extensively O-acetylated PG from Neisseria gonorrhoeae FA19 (O-PG), and (ii) lysozyme-sensitive, O-acetyl-deficient PG from N. gonorrhoeae RD5 (non-O-PG). Male Lewis rats were injected intradermally in the tail with 200 micrograms of PG emulsified in mineral oil and water (1:1) or with the oil and water emulsion alone (controls). Quantitation of hind paw size indicated that macromolecular PG of various chemical and physical forms induced paw swelling (P versus controls, less than 0.01) that was evident at about day 14 and that reached a maximum at about day 24. PG-mediated paw swelling was accompanied by intense synovitis with some cartilage and bone involvement. The minimal arthropathic dose of soluble macromolecular PG was 20 micrograms per rat. Of particular interest was that macromolecular O-PGs from strain FA19 caused considerably more extensive swelling than did either their RD5 non-O-PG counterparts or the homologous FA19 PG that had been de-O-acetylated by mild alkali treatment. This suggested that the persistence of hydrolase-resistant high-molecular-weight fragments, afforded by extensive O-acetylation, may be important for optimal expression of arthropathic activity. However, oligomeric PG was not an absolute requirement, since even low-molecular-weight fragments, including the anhydro-muramyl-containing disaccharide peptide monomer released by growing gonococci, were also arthritogenic. Experiments employing purified gonococcal lipopolysaccharide indicated that the arthropathic activity of PG preparations was not due to contaminating lipopolysaccharide. Based on the arthritogenicity of gonococcal PG in this model system, we suggest that PG may play a role in the pathogenesis of gonococcal arthritis, and that such an activity might be potentiated by the persistence of hydrolase-resistant O-PG.

Citing Articles

Vertebrate and Invertebrate Animal and New In Vitro Models for Studying Biology.

Girgis M, Christodoulides M Pathogens. 2023; 12(6).

PMID: 37375472 PMC: 10301118. DOI: 10.3390/pathogens12060782.


The SGNH hydrolase family: a template for carbohydrate diversity.

Anderson A, Stangherlin S, Pimentel K, Weadge J, Clarke A Glycobiology. 2022; 32(10):826-848.

PMID: 35871440 PMC: 9487903. DOI: 10.1093/glycob/cwac045.


Mechanism of peptidoglycan -acetyltransferase A as an -acyltransferase.

Jones C, Anderson A, Clarke A Proc Natl Acad Sci U S A. 2021; 118(36).

PMID: 34480000 PMC: 8433495. DOI: 10.1073/pnas.2103602118.


Anti-Virulence Therapeutic Approaches for .

Lim K, Mullally C, Haese E, Kibble E, McCluskey N, Mikucki E Antibiotics (Basel). 2021; 10(2).

PMID: 33494538 PMC: 7911339. DOI: 10.3390/antibiotics10020103.


Structural basis for the acetyltransferase function of the extracytoplasmic domain of OatA from .

Jones C, Sychantha D, Howell P, Clarke A J Biol Chem. 2020; 295(24):8204-8213.

PMID: 32350117 PMC: 7294091. DOI: 10.1074/jbc.RA120.013108.


References
1.
Schwab J, Ohanian S . Degradation of streptococcal cell wall antigens in vivo. J Bacteriol. 1967; 94(5):1346-52. PMC: 276831. DOI: 10.1128/jb.94.5.1346-1352.1967. View

2.
ROSENTHAL R, Gfell M, Folkening W . Influence of protein synthesis inhibitors on regulation of extent of O-acetylation of gonococcal peptidoglycan. Infect Immun. 1985; 49(1):7-13. PMC: 262049. DOI: 10.1128/iai.49.1.7-13.1985. View

3.
Glick A, Ranhand J, Cole R . Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes. Infect Immun. 1972; 6(3):403-13. PMC: 422548. DOI: 10.1128/iai.6.3.403-413.1972. View

4.
Martin J, Fleck J, Mock M, Ghuysen J . The wall peptidoglycans of Neisseria perflava, Moraxella glucidolytica, Pseudomonas alcaligenes and Proteus vulgaris strain P18. Eur J Biochem. 1973; 38(2):301-6. DOI: 10.1111/j.1432-1033.1973.tb03062.x. View

5.
Kohashi O, Pearson C, Watanabe Y, Kotani S, Koga T . Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds. J Immunol. 1976; 116(6):1635-9. View